Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza (RICH-3)

This study has been completed.
Erasmus Medical Center
Information provided by:
Leiden University Medical Center Identifier:
First received: February 9, 2010
Last updated: January 27, 2012
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
No publications provided by Leiden University Medical Center

Publications automatically indexed to this study by Identifier (NCT Number):